Corbus Pharmaceuticals’ Post

Join PDA Southern California Chapter on August 15 for our Visible Particulates Symposium at BioscienceLA Speakers include Austin Caudle, Xueyuan (Shawn) Wang, Robin Manouchehri, Amgen, Robert Meisenhelter III, Sladjan Maksimovic, Colleen O'Brien Sonia Adamidis New added topic: "Contamination controls for the rubber stoppers" ^ Understanding Visible Particles and Patient Safety ^ Particulate challenges in Autologous Cell Therapy ^ Enforcement Actions in relation to Particles ^ A Study in Improving Sustainability, whilst Reducing Manufacturing Costs ^ Annex 1, Compliant Contamination Control Strategies ^ Achieving Particle Reduction via Supplier Annex 1 Strategies and Innovation in RTF Packaging Register Here: https://lnkd.in/gdAcJFZc https://lnkd.in/gJpdGd7h Amgen Kite Pharma Gerresheimer SCHOTT Redica Systems West Pharmaceutical Services

We all know the importance of Sample Management. Why not join #Avantor next week at our 4th EU Sample Management Symposium?! See below for more details and the links to register - see you there !! #Pharma #biotech #Avantorsetsscienceinmotion #SLAS2024

Not really. My patent #10,646,535 proves an engineering method which can be used as an intellectual property fence to protect development up botanical new drug. Botanical new drug will be where most of this development occurs. I do agree that cannabis will be somewhat of a novelty soon as we begin REAL research and REAL study of the endocannabinoid system. Why develop with cannabis when you can develop with endocannabinoids? There is no doubt the world changed on 4/30/24...

Looking forward presenting in 2 weeks, for the first time externally, our work on shipments with clinical samples, their carbon footprint, and how we can reduce (and get savings along!)... The title of that Symposium is "Challenges and Solutions of Sample Management": I believe that a challenge (to come) is how we will operate by 2030 in a context of targeted carbon-neutrality (scopes 1, 2 & 3). I will present there one solution we built, which will help a lot in that direction - among others! #environmental #sustainability #shipments #clinical #samples #Novartis

🌿 Explore the therapeutic potential of Chrysin, a natural flavonoid! 🌿 This highly cited article provides a comprehensive review of its wide-ranging benefits, molecular targets, and bio-pharmaceutical aspects. Discover Chrysin research! 🧪 https://ow.ly/1SCi50Qj0VX 📚 Author(s): Anuj Garg* and Shashank Chaturvedi #Research #Pharmacology #BenthamScience

🔬📚 In this issue of "Small Molecule Highlights," we bring you 5 new small molecules out of recent drug discovery journals. These molecules target a diverse selection of targets, including Ketohexokinase-C & A, GPR183, FLT3, PARP7, and MDM2. Enjoy! 🌟💊 Check out the full article here ➡️ https://lnkd.in/dirjU4zC #drugdesign #drugdiscovery #drughunter #pharma #biotech #healthcare #medicine #pharmacology #smallmolecules

Everybody knows that #Mitochondria are the powerhouse of the cell, but what if you need to get rid of a dysfunctional powerhouse? Then you need lysosomes! But what if lysosome function is compromised? Researchers from the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences have identified an alternative mechanism for offloading dysfunctional mitochondrial – ejecting them via secretion in large extracellular vesicles. #LiveCell #Imaging for this study was performed using a Nikon ECLIPSE Ti inverted microscope with spinning disk #Confocal #Microscopy system. Click to view the article: https://lnkd.in/eTTGTt6Q

🔍 Explore the Evolution of Biopharma Hotbeds! 🌐 Then and Now: What’s Changed—and What Hasn’t—in Some Early Biopharma Hotbeds. Read the insightful article: https://hubs.la/Q02hd4_T0 #Biopharma #Hotbeds #IndustryEvolution #BioSpace

Phase 2 & 3 Data Readouts Left This Quarter.. Here's a few of the biggest to watch 👇 UroGen Pharma - Phase 3 data from ENVISION study Viking Therapeutics, Inc. - Phase 2b data from VOYAGE study. Lipocine Inc. - Topline results from pivotal PK study. See table below for ph 2 & 3 readouts this quarter. --- 👋 I'm Dominic Vacchiano, Co-founder of BiopharmIQ by Amp. We provide biopharma data to help with your BD/investing activities. 📰 Each week we share clinical/regulatory/funding news in an easy-to-digest format. #biotech #biopharma

There is some exciting progress to watch from Immix Biopharma (Nasdaq: IMMX) regarding CAR-T treatment for AL Amyloidosis! https://lnkd.in/eiDpRHaQ #amyloidosis